Real-world outcomes for patients with relapsed or refractory (R/R) aggressive B-cell non-Hodgkin's lymphoma (aBNHL) treated with commercial tisagenlecleucel: Subgroup analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) registry Meeting Abstract
| Authors: | Landsburg, D. J.; Frigault, M.; Heim, M.; Foley, S. R.; Hill, B. T.; Ho, C. M.; Jacobson, C. A.; Jaglowski, S.; Locke, F. L.; Ram, R.; Riedell, P. A.; Shah, G. L.; Popplewell, L. L.; Tiwari, R.; Lim, S.; Majdan, M.; Masood, A.; Pasquini, M. C.; Turtle, C. J. |
| Abstract Title: | Real-world outcomes for patients with relapsed or refractory (R/R) aggressive B-cell non-Hodgkin's lymphoma (aBNHL) treated with commercial tisagenlecleucel: Subgroup analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) registry |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 1584 |
| End Page: | 1587 |
| Language: | English |
| ACCESSION: | WOS:000893223201242 |
| DOI: | 10.1182/blood-2022-158822 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
